HOME >> BIOLOGY >> NEWS
Controversial UK badger killings analyzed by UC Davis expert

A UC Davis professor is co-author of a report released today in Great Britain that says the controversial practice of killing wild badgers to prevent tuberculosis in cattle apparently does no good -- and may make matters worse.

Rosie Woodroffe, UC Davis assistant professor of conservation biology, is an authority on the biology of the European badger (Meles meles). The new report, commissioned by the British Department for Environment, Food and Rural Affairs (Defra), is sure to be widely discussed in the UK, particularly by farming interests and badger protectionists. Those groups have battled for 30 years over the role that wild badgers may play as reservoirs and vectors of bovine tuberculosis, which can be transmitted through unpasteurized milk to people.

"In Britain, this is the largest wildlife controversy," Woodroffe said. "It's a massive issue not only because this is a zoonotic disease -- one that can spread from animals to humans -- but also because we just don't have that much wildlife left in Britain, and badgers are amazingly charismatic."

The badger-cattle controversy is similar to the fights between ranchers and conservationists over wolf re-introductions in the U.S. and Canada, Woodroffe said. "You have one lot saying, 'This animal is affecting my livelihood,' and another lot saying, 'This animal is beautiful and shouldn't be killed.' "

North American badgers (Taxidea taxus) do not carry bovine tuberculosis, Woodroffe noted.

Today's report by the seven-member Independent Scientific Group on Cattle TB says that a field experiment begun in 1998 shows that "reactive culling," which kills badgers on and around farms where bovine tuberculosis has occurred, did not prevent future TB outbreaks in those areas.

In fact, there were 27 percent more cases of bovine TB in the culled areas than in areas where no culling occurred.

"Our finding suggests that 25 y
'"/>

Contact: Sylvia Wright
swright@ucdavis.edu
530-752-7704
University of California - Davis
4-Nov-2003


Page: 1 2

Related biology news :

1. Terminator tussle: Controversial technology needed, experts say
2. Science-Based Decision Guide May Be Answer To EPAs Controversial Rule
3. Human Ancestors Went Out Of Africa And Then Came Back: NYU/SUNY-Albany Research Team Proposes Controversial New Model for Evolution of Humans
4. Field trials used to investigate the social lives of badgers
5. Human rights in Peru: AAAS analysis doubles previous estimates of killings
6. Dinosaur fossil record compiled, analyzed
7. West Nile Virus cases analyzed for prevalence and symptoms
8. New angle needed to get pike out of Lake Davis
9. UC Davis to begin identifying eligible families for study on environmental factors in autism
10. NSF establishes center for biophotonics at UC Davis
11. UC Davis mathematician, neuroscientist win Sloan Fellowships

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Controversial badger killings analyzed Davis expert

(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
(Date:2/5/2015)... 2015 New Market Research Reports ... Forecasts To 2020 has Been Added to GrandViewReseach.com Report ... expected to reach USD 5.10 billion by 2020, according ... IR cameras help identify the site of tissue damage ... surging demand in medical imaging applications. They have been ...
(Date:2/5/2015)... 30, 2015  It is gratifying to see that ... for genomic science as a means to better understand ... treatment.  I was honored to participate in today,s White ... program. Since the 1980s my teams ... the first sequenced genome of a free living organism, ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
Cached News: